IBRX-042 In Participants With HPV-Associated Tumors

Clinical trial NCT05976828 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05976828
Sponsor: ImmunityBio, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HPV-Related Carcinoma

Start date: 2024-06-14
Primary completion: 2027-09-02
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.